Trial Profile
A Phase 1, First in Man, Safety, Tolerability and Pharmacokinetic Study of Single Ascending and Multiple Cutaneous Doses of LEO 29102 2.5 mg/g Cream or LEO 29102 Cream Vehicle in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs LEO 29102 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; First in man
- Sponsors LEO Pharma
- 27 Nov 2014 New trial record